PROFILE実績・経験
Sawako Kira吉良佐和子
Medical Communication Planner
Medical Writer
Medical Writer
医療用医薬品専門の広告代理店で約30年にわたり、製薬企業・医療用医薬品の学術資材の企画・制作に携わる。
Medical Writerとして新薬発売時の各種基本資材をはじめ医師向け・患者さん向け、MR・MSL向けなどの学術資材の企画・制作を担当。また、Medical Communication Plannerとして、新薬発売時における販売戦略のフレームならびに施策立案を行う。
Medical Writerとして新薬発売時の各種基本資材をはじめ医師向け・患者さん向け、MR・MSL向けなどの学術資材の企画・制作を担当。また、Medical Communication Plannerとして、新薬発売時における販売戦略のフレームならびに施策立案を行う。
いずれの業務においても、日本製薬工業協会が定めるプロモーションコードを遵守し、エビデンスに基づく企画・制作を行っています。
主な経験・担当疾患領域
| 領域 | 疾患 | 主なプロジェクト・制作資材 |
|---|---|---|
| 希少疾患 | 血友病 非典型溶血性尿毒症症候群、発作性夜間ヘモグロビン尿症 |
新発売時の学術資材一式、専門医取材資材、患者取材資材など |
| 癌 | 肺癌、甲状腺癌、多発性骨髄腫 | 新発売時の学術資材一式、専門医取材資材、施設取材資材、MSL研修資材など |
| 循環器 | 慢性血栓塞栓性肺高血圧症、肺動脈性肺高血圧症 | 新発売時の学術資材一式、専門医取材資材、患者取材資材、医師向け疾患啓発サイト、患者向け疾患啓発サイトなど |
| 免疫・感染症 | HIV/AIDS、関節リウマチ、潰瘍性大腸炎、小児用ワクチン、アナフィラキシー | 新発売時の学術資材一式、専門医取材資材、医師座談会資材、患者会取材資材、医師向け定期情報誌など |
| 代謝性疾患 | 肥満症、糖尿病 | 新発売時の学術資材一式、患者取材資材、施設取材資材など |
| 中枢神経系疾患 | 片頭痛 | 新発売時の学術資材一式など |
| 皮膚疾患 | 尋常性痤瘡 | 新発売時の学術資材一式など |
| 婦人科系疾患 | 子宮内膜症、経口避妊薬、更年期治療薬 | 新発売時の学術資材一式など |
※上記疾患領域における関連疾患として関与した領域
再生不良性貧血、血栓性微小血管障害症、先天性心疾患、門脈圧亢進症、膠原病
（強皮症、全身性エリテマトーデス、シェーグレン症候群など）、クローン病、骨粗鬆症など
再生不良性貧血、血栓性微小血管障害症、先天性心疾患、門脈圧亢進症、膠原病
（強皮症、全身性エリテマトーデス、シェーグレン症候群など）、クローン病、骨粗鬆症など
受賞歴
Clio Health Innovators 2023の1 人として選出
2023 年、第2 回Clio Health Innovators 21 人の中の一人として選出されました（McCann Health 所属時）
Clio Health Innovators 2023: Meet 21 Leaders Driving Progress in Healthcare Marketing | Muse by Clios
- McCann Health Japan, an IPG Health company
Sawako Kira
Writing Director
- Before joining McCann Health Japan in 2014, Sawako Kira worked as a medical writer at an advertising agency specialized in ethical pharmaceuticals for 20+ years, where she engaged in planning and production of new product launch materials as well as scientific materials for doctors, patients and sales reps.
- How you bring creativity and innovation to your work
- I attend academic conferences in areas pertaining to my role, not only to absorb the latest scientific information, but also to observe trends within society and reactions of participating physicians. Then I review relevant literature and consider if I can propose a new asset that is of interest to the client.
- A recent project you’re proud of
- A pitch win for a new drug for treating hemophilia. I am proud of the win because we contemplated and proposed strategy and a framework for a tactical program based on medical evidence, and then we developed our proposal through a highly collaborative team effort. I assigned a junior writer for development of a MOA illustration and supported her where needed. Her MOA illustration was well appreciated by the client and contributed to the win. Being able to cultivate ability and motivation of a young writer was just as fulfilling as the pitch win.
- I am also proud of communication with my client’s pulmonary arterial hypertension (PAH) team: I attended a scientific meeting of the Japanese Pulmonary Circulation and Pulmonary Hypertension Society, which took place in Tokyo in the summer of 2022, and put together a report on presentations that I attended and shared the report with my client’s PAH team. The report was shared with their PAH MSLs and was used for KOL communications. It led to high praise for McCann Health Japan and resulted in a brief for a new material development. It was gratifying that what I did was so well received and led to new business for the agency.
- What you’re most excited about right now in the health space
- The development and clinical application of A.I.-based diagnostic technology is progressing in various areas including cardiovascular, which I engage with. I am excited about the potential use of A.I. in the medical and health fields.